20th Cancer Immunotherapy Meeting (CIMT) 2022 

20th Cancer Immunotherapy Meeting (CIMT) 2022 

May 10–12, 2022 |  Mainz, Germany

Transform your cell and gene therapy manufacturing

 

Join us at the 2022 CIMT Annual Meeting, Europe’s largest cancer immunotherapy focused meeting. Learn and exchange ideas on the newest advances in the field, from basic research to the latest clinical developments. 

This year, we are pleased to contribute to the meeting with our face-to-face scientific seminar. Unable to attend in person? You can also tune in to the livestream, and listen in as we discuss the complete workflow for large scale clinical T cell manufacturing using the latest technologies.

Visit us at our booth, where we will showcase our innovative, fully automated gene manufacturing CliniMACS Prodigy® Platform, along with the CliniMACS Electroporator and CliniMACS® Formulation Unit with multiple daily live demos. 

Rheingoldhalle Congress Center
Miltenyi Biotec booth
May 10–12, 2022 | Exhibit opening hours
Tuesday 8:30 a.m.–6:00 p.m.
Wednesday 8:30 a.m.–6:00 p.m.
Thursday 7:30 a.m.–6:00 p.m.

What are you interested in?

Scientific seminarScientific postersLive demoTechnologiesApplications and publications
 

Scientific seminar

From gene-editing manufacturing to analytics: the complete clinical T cell workflow

Join our scientific talk and gain valuable insight into:

  • How to successfully translate T cell research workflows into clinical applications
  • Solutions to gene-engineer T cells  for large-scale manufacturing
  • Optimization strategies for IPC and QC flow assays in the context of engineered T cell products
Wednesday, May 11, 2022
5:30 p.m.–6:00 p.m.
 
Rheingoldhalle Congress Center
Gutenberg Hall B

 
Presenter: Sophia Lollies, M.Sc.

Global Product Manager, Translational Immunology Engineered Immune Cells  
Miltenyi Biotec 

Sophia Lollies is a Global Product Manager for the clinical engineered cells portfolio, including CAR T cell immunotherapy, at Miltenyi Biotec. Since 2021 she has been working with R&D and the Clinical Development team to advance the development of tools for enabling CAR T cell  therapy. 

Before that,  as part of the Industry Process Development team, Sophia supported the development of clinical applications on the CliniMACS® Prodigy for industrial customers. Prior to joining Miltenyi Biotec, she worked as an intern at Bayer Ag in the field of Global Screening and Automation after complementing her M.Sc. at the LIMES Institute in Bonn, Germany.

Read more …
 

Scientific posters

As in previous years, we have range of our own scientific posters – check them out,  and come along for the discussion. 

High throughput screening methods reveal novel tumor marker combination THY1-EPCAM for adapter CAR T cell therapy in ovarian cancer


Presenter: Manuel Martinez-Osuna
 
May 10–12, 2022 | 3:30 p.m.–6:00 p.m.
GMP-compliant flow cytometric cell sorting and expansion of MACS GMP CD137+ tumor infiltrating T cells using MACS® GMP Fluorochromes, MACSQuant® Tyto® Cell Sorter and CliniMACS Prodigy® 

Presenter: Alina Kurowski and Laura Schlahsa
 
May 10–12, 2022 | 3:30 p.m.–6:00 p.m.
Robustness testing of an assay for flow cytometric CAR persistence determination


Presenter: Inga Herfort, Stefanie Biedermann
 
May 10–12, 2022 | 3:30 p.m.–6:00 p.m.
 
Workflow development for computational prediction and validation of tumor-associated neoantigens


Presenter: Johanna Engeln
 
May 10–12, 2022 | 3:30 p.m.–6:00 p.m.
 

Live demo

Non-viral strategies for cell and gene therapy - join us for a live demo of the new CliniMACS® Electroporator

Join us and learn about:

  • potential for gene-engineering by clinical-scale electroporation
  • GMP-compliant and automated large-scale transfection
  • flexible and adjustable settings for electroporation of various cell types

Duration: 20–30 Min.

Dates and Time:

  • Day 1, May 10: 4:00 p.m.–4:30 p.m.
  • Day 2, May 11: 1:00 p.m.–1:30 p.m. 
  • Day 2, May 11: 4:00 p.m.–4:30 p.m.

Watch the video to get a glimpse.

video preview
Icon_play-xl2_whiteCreated with Sketch.
CliniMACS® Electroporator: Automated and closed-system electroporation
 

Technologies

CliniMACS Prodigy Platform

Automated cell manufacturing 
on a closed and scalable platform
CliniMACS Plus System

Automated clinical-scale  
cell enrichment or depletion
Clinical flow cytometry

Clinical flow cytometry - 
diagnostic and QC reagents for cell manufacturing
MACS Cell Separation

Automated cell separation systems
 

Applications and publications

Application 

Clinical-grade CAR T cell manufacturing via viral transduction        
Application

Manufacturing of gene-engineered hematopoietic stem cells
Nature Communications publication

Manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
Nature Medicine publication

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies

Contact us

Interested and would like to know more? Send your inquiry to:

Dr. Aparajita Singh, Global Product Manager  

aparajitas@miltenyi.com

Seems like you are coming from USA!
Do you want to visit our website in your country?

Copyright © 2022 Miltenyi Biotec and/or its affiliates. All rights reserved.